Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-013105.pdf 0000899243-19-013105.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-013106.pdf 0000899243-19-013106.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-138295.pdf 0001193125-19-138295.rtf 0001193125-19-138295.xls View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-19-138376.pdf 0001193125-19-138376.rtf 0001193125-19-138376.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-012060.pdf 0000899243-19-012060.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-129478.pdf 0001193125-19-129478.rtf 0001193125-19-129478.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-010939.pdf 0000899243-19-010939.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-010940.pdf 0000899243-19-010940.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000919574-19-002943.pdf 0000919574-19-002943.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-103909.pdf 0001193125-19-103909.rtf 0001193125-19-103909.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon